Paper17023659
Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis.
Neumann M and 18 others. Science, 2006. Cited by 5,424 papers, by iCite.
Cite this record
ConductScience Library. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Papers, record 17023659. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17023659
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Amyotrophic Lateral Sclerosis | Major topic |
| Brain Chemistry | Major topic |
| DNA-Binding Proteins | Major topic |
| Dementia | Major topic |
| Spinal Cord | Major topic |
| Ubiquitin | Major topic |
| Amino Acid Sequence | |
| Antibodies, Monoclonal | |
| Cerebral Cortex | |
| Fluorescent Antibody Technique | |
| Hippocampus | |
| Humans | |
| Immunoblotting | |
| Molecular Sequence Data | |
| Motor Neurons | |
| Neurons | |
| Peptide Fragments | |
| Phosphorylation |
Source PubMed
Grants5
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| P01 AG019724 | NIA NIH HHS | United States | P01AG019724 | PubMed and NIH | NIH RePORTER |
| AG10124 | NIA NIH HHS | United States | P01AG010124 | PubMed and NIH | NIH RePORTER |
| AG17586 | NIA NIH HHS | United States | P01AG017586 | PubMed and NIH | NIH RePORTER |
| T32 AG00255 | NIA NIH HHS | United States | T32AG000255 | PubMed and NIH | NIH RePORTER |
| P30AG010124 | NIH | NIH RePORTER |
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT04244630 | Mitochondrial Capacity Boost in ALS (MICABO-ALS) Trial | Background |
Source ClinicalTrials.gov
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 17023628 | Neurodegenerative diseases. Picking apart the causes of mysterious dementias. | https://conductscience.org/library/papers/17023628 |
Source PubMed
Cited by3,552
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5,424 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42988796 | Shared and distinct gain-of-function consequences from pathologic cytoplasmic versus nuclear TDP-43. | Cell Death Dis | 2026 | https://conductscience.org/library/papers/42988796 | PubMed |
| 42983429 | The TNKS/PI31-proteasome axis as a central node in TDP-43 neuropathies. | J Biomed Sci | 2026 | https://conductscience.org/library/papers/42983429 | PubMed |
| 42959345 | Disease-guided targeted protein degradation and clearance: matching strategies to pathological protein states. | Front Med (Lausanne) | 2026 | https://conductscience.org/library/papers/42959345 | PubMed |
| 42942798 | Targeting of Protein Persulfidation in Aging and Age-Related Disorders. | Pharmaceutics | 2026 | https://conductscience.org/library/papers/42942798 | PubMed |
| 42942116 | Beyond Monogenic Inheritance: Emerging Genetic Architecture of Amyotrophic Lateral Sclerosis. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42942116 | PubMed |
| 42934377 | The cGAS-STING Pathway in Neuroinflammation and Neurological Disease: Mechanisms, Disease Contexts, and Periphery-to-Brain Communication. | Cell Mol Neurobiol | 2026 | https://conductscience.org/library/papers/42934377 | PubMed |
| 42934257 | Neuromuscular junction pathology in amyotrophic lateral sclerosis and emerging molecular therapeutic strategies. | J Hum Genet | 2026 | https://conductscience.org/library/papers/42934257 | PubMed |
| 42931998 | HSV-1 ICP0 expression induces formation of nuclear TDP-43 assemblies. | J Neurovirol | 2026 | https://conductscience.org/library/papers/42931998 | PubMed |
| 42922081 | Riluzole-Derived Benzo[d]thiazoles as CK1δ Inhibitors for Amyotrophic Lateral Sclerosis-Related Neurodegeneration. | ChemMedChem | 2026 | https://conductscience.org/library/papers/42922081 | PubMed |
| 42894639 | OGT regulates RNA-binding protein nucleocytoplasmic partitioning, but this fails in amyotrophic lateral sclerosis. | iScience | 2026 | https://conductscience.org/library/papers/42894639 | PubMed |
| 42882522 | Olfactory Swab-Derived Human Neuroepithelium Cell Culture as a Novel Model to Study Neurodegeneration-Related Proteins. | Cells | 2026 | https://conductscience.org/library/papers/42882522 | PubMed |
| 42875809 | Levetiracetam restores GABAergic function and network homeostasis following Vps35 deficiency in excitatory neurons. | Transl Neurodegener | 2026 | https://conductscience.org/library/papers/42875809 | PubMed |
| 42861938 | Stress granules at the crossroads of the proteostasis network. | RNA Biol | 2026 | https://conductscience.org/library/papers/42861938 | PubMed |
| 42860740 | Integrative ALS therapy: gene targeted therapy by base editing and potential exercise rehabilitation as synergistic strategies for functional recovery. | Phys Act Nutr | 2026 | https://conductscience.org/library/papers/42860740 | PubMed |
| 42856458 | Divergent PML and Nucleolar Body Programs Distinguish Protected from Vulnerable Neurons in FTLD-TDP. | Res Sq | 2026 | https://conductscience.org/library/papers/42856458 | PubMed |
| 42856249 | Early life social isolation primes flies for more rapid TDP-43 dependent neurodegeneration later in life. | bioRxiv | 2026 | https://conductscience.org/library/papers/42856249 | PubMed |
| 42854693 | Anti-HDGFL2 cryptic protein antibodies provide a sensitive readout of TDP-43 pathology and clinical disease features. | Cell Rep Med | 2026 | https://conductscience.org/library/papers/42854693 | PubMed |
| 42851781 | Minding the gates: dual cell-autonomous and non-cell-autonomous mechanisms of TBK1 in ALS/FTD. | Front Neurosci | 2026 | https://conductscience.org/library/papers/42851781 | PubMed |
| 42835448 | Global research architecture of RNA-binding proteins in neurodegenerative diseases: a web of science bibliometric study with PubMed record verification, 2001-2025. | Front Aging Neurosci | 2026 | https://conductscience.org/library/papers/42835448 | PubMed |
| 42834122 | TBK1 eliminates aggregation-prone monomeric TDP-43 through an IFNβ-immunoproteasome pathway in ALS models. | EMBO Rep | 2026 | https://conductscience.org/library/papers/42834122 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| TARDBP | 23435 | Swiss-Prot's references | https://conductscience.org/library/genes/23435 | NCBI Gene |
| MAPT | 4137 | PubTator's text mining | https://conductscience.org/library/genes/4137 | NCBI Gene |
| SNCA | 6622 | PubTator's text mining | https://conductscience.org/library/genes/6622 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/17023659
GET https://conductscience.org/api/papers/v1/17023659/cited_by?page=2